Evoke Pharma Balance Sheet - Annual (NASDAQ:EVOK)

Add to My Stocks
$2.59 $0.06 (2.26%) EVOK stock closing price Jun 22, 2018 (Closing)

A balance sheet is one of the three key financial statements released by a publicly listed company like Evoke Pharma, and helps in stock analysis. As in our Evoke Pharma stock analysis, analyzing a company also involves looking at the company's assets and liabilities as given in its balance sheet, which can be used to measure financial performance. Annual results are typically accompanied with the company releasing financial statements. The balance sheet shows total liabilities of $5.77M and shareholders equity of $2.16M. Evoke Pharma revenue and Evoke Pharma operating cash flow are important in understanding the financial capacity of the company.

View latest 10 year balance sheet data to check Evoke Pharma financial performance.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011
Cash7.67M9M8.69M14.15M24.19M--
Marketable Securities-------
Receivables-------
Inventory-------
Raw Materials-------
Work In Progress-------
Finished Goods-------
Notes Receivable-------
Other Current Assets---1.09M---
Total Current Assets
7.93M9.28M9.52M15.24M24.43M--
Property Plant & Equipment-------
Accumulated Depreciation-------
Net Property Plant & Equipment
-------
Investment & Advances-------
Other Non-Current Assets-------
Deferred Charges-------
Intangibles-------
Deposits & Other Assets-------
Total Assets
7.94M9.29M9.53M15.3M24.98M--
Notes Payable-------
Accounts Payable1.04M--1.01M---
Current Portion Long-Term Debt----1.44M--
Current Portion Capital Leases-------
Accrued Expenses1.02M------
Income Taxes Payable-------
Other Current Liabilities-------
Total Current Liabilities
2.07M1.41M1.83M1.87M2.28M--
Mortgages-------
Deferred Taxes/Income-------
Convertible Debt-------
Long-Term Debt--4.23M4.24M1.51M--
Non-Current Capital Leases-------
Other Long-Term Liabilities3.7M4.09M-----
Total Liabilities
5.77M5.5M6.06M6.11M3.8M1.55M-
Minority Interest-------
Preferred Stock-----18.22M-
Common Stock Net-------
Capital Surplus73.2M62.59M51.52M45.12M43.87M--
Retained Earnings-71.03M-58.8M-48.06M-35.93M-22.69M-19.85M-
Treasury Stock-------
Other Liabilities-------
Shareholders Equity2.16M3.78M3.46M9.18M21.18M-1.43M-
Total Liabilities & Shareholders Equity7.94M9.29M9.53M15.3M24.98M--
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

The latest Evoke Pharma stock price, and Evoke Pharma historical stock prices show the stock price movement over time, and the Evoke Pharma PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:

  • Assets: Anything that the Evoke Pharma company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. Evoke Pharma had total assets of $7.94M.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Evoke Pharma's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for EVOK stock stand at $5.77M.

Evoke Pharma Balance Sheet - Key Ratios